HomeRLMD • NASDAQ
add
Relmada Therapeutics Inc
Previous close
$6.10
Day range
$6.19 - $6.57
Year range
$0.24 - $7.50
Market cap
668.22M USD
Avg Volume
2.41M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 20.33M | 6.59% |
Net income | -19.87M | -6.49% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 93.01M | 107.10% |
Total assets | 94.00M | 105.17% |
Total liabilities | 7.49M | -27.24% |
Total equity | 86.51M | — |
Shares outstanding | 104.89M | — |
Price to book | 5.17 | — |
Return on assets | -93.37% | — |
Return on capital | -105.93% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -19.87M | -6.49% |
Cash from operations | -14.60M | -65.87% |
Cash from investing | -76.93M | -778.07% |
Cash from financing | 93.64M | 54,386.89% |
Net change in cash | 2.11M | -11.01% |
Free cash flow | -23.01M | -905.56% |
About
Founded
2004
Headquarters
Website
Employees
17
